Lincoln Pharmaceuticals Limited
Share Price Target & Analysis
NSE:LINCOLN
VWAP
Open
Close
High
Low
52 Week High
-20.90 (-3.35%)
LINCOLN
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Standard
Quality
Steel
Valuation
#Analysis
NSE: LINCOLN Share Price Financial Analysis & Valuation
Lincoln Pharmaceuticals Limited (LINCOLN) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Micro Cap company with Market Capitalization of Rs 706.4 (in Cr). Total number of free float shares are 2 (in Lacs).
Lincoln Pharmaceuticals Limited is listed on NSE with Exchange ID - INE405C01035 and trading code is NSE:LINCOLN with short name Lincoln Pharma.
In the past 1 year, Lincoln Pharmaceuticals Limited has declared an equity dividend of Rs 0.3 per share. At the current share price of LINCOLN at Rs 602.60, this results in a dividend yield of 0.05 %.
As per the Fundamental Analysis of NSE:LINCOLN, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine LINCOLN underlying value and future prospects. All of this data is available in LINCOLN financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:LINCOLN, it is clearly understood that LINCOLN is Standard performer in terms of earnings and profit margins with an EPS of 51.12. NSE:LINCOLN book value per share as of today is 396.34. The current price to book ratio for LINCOLN as of Sep 15, 2026 is 1.52.
Valuation of the Stock: The current valuation of LINCOLN stock is like Steel which means currently the stock is Moderately Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of LINCOLN whether to BUY this stock at current valuation. The delivery percentage of LINCOLN is 17268% is very crucial parameter which shows that 17268% investors are anticipating that the price of LINCOLN share should go up with VWAP at 615.45.
Now, the main question is whether to BUY or SELL, NSE:LINCOLN at current valuation.
As per latest Analysis No. #1509:-
⇑ STRONG BUY LINCOLN if All Greens
⇗ BUY LINCOLN (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD LINCOLN (With Stop Loss) if only 1 Green
⇘ SELL LINCOLN if NO Green Indicator
NSE: LINCOLN Share Price Today (Sep 15, 2026)
(Lincoln Pharmaceuticals Limited Daily Analysis on the basis of LINCOLN Intraday Graph & Trend)
Lincoln Pharmaceuticals Limited share price moved Down by -3.35% from its previous close of Rs 623.5. LINCOLN stock last traded price is 602.60. LINCOLN share price trend is Down with a total of 62529 stocks traded till now. It has touched an intraday high of Rs 630.9 and an intraday low of Rs 600. The LINCOLN trading at 602.60, Down by Rs. -20.90, or -3.35 percent which suggests that most of the Traders are anticipating that the price of LINCOLN share should go Down.
NSE: LINCOLN Share Price Tomorrow Prediction
(Lincoln Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of LINCOLN)
Lincoln Pharmaceuticals Limited share price moved Down by -3.35%. LINCOLN share price short term trend is Down. It suggests that LINCOLN Share Price for Tomorrow remains the same with VWAP at 615.45 will be treated as stop loss for intraday traders. Lincoln Pharmaceuticals Limited Long term investors can follow the LINCOLN long term trend as mentiond in future forecast table.
NSE Code |
NSE: LINCOLN |
LINCOLN Share Price Today |
602.60 |
LINCOLN Share Price Target Prediction for 2026 ^ |
461.3 - 642.4 |
LINCOLN Share Price Target Prediction for 2027*^ |
642.4 - 824.4 |
LINCOLN Share Price Target Prediction for 2028*^ |
824.4 - 882.1 |
LINCOLN Share Price Target Prediction for 2029*^ |
926 |
LINCOLN Share Price Target Prediction for 2030*^ |
953 |
LINCOLN Share Price Target Prediction for 2035*^ |
1038 |
| LINCOLN Current Book Value |
394.4 |
*Lincoln Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^LINCOLN share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
LINCOLN Technical Analysis
Candlestick Pattern: @637.5| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 630.62 | BUY | 631.47 | BUY |
| MA_12 | 619.98 | BUY | 622.84 | BUY |
| MA_20 | 619.07 | BUY | 618.62 | BUY |
| MA_32 | 606.73 | BUY | 614.78 | BUY |
| MA_50 | 606.31 | BUY | 613.94 | BUY |
| MA_100 | 626.59 | BUY | 611.34 | BUY |
| MA_200 | 580.69 | BUY | 599.49 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 636.47 | OverBought |
| MACD | 2.47 | BUY |
| ADX | 29.8 | Strong Trend |
| DMI (+/-) | 24.81 / 8.47 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 62.95 | Neutral |
| STOCHASTIC_K (Fast) | 70.31 | Neutral |
| STOCHASTIC_D (Slow) | 76.45 | Neutral |
| CCI | 152.1 | BUY |
| PSAR | 599.86 | BUY |
| TRUE RANGE | 10.55 | BUY |
| ATR | 16.94 | BUY |
| WILLIAMS R | -24.04 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 80.47 | Overbought |
| STOCHASTIC RSI D | 93.49 | Overbought |
| MOMENTUM | 41 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 15.91% |
| 3 Months | -0.05% |
| 1 Month | 6.87% |
| 1 Week | 3.1% |
| Action | Overall (%) |
|---|---|
| BUY | 83% |
| NEUTRAL / HOLD | 17% |
| SELL | 0% |
Most popular Questions & Answers about LINCOLN (/ FAQ LINCOLN)
Lincoln Pharmaceuticals Limited stock last traded price is 602.60. LINCOLN share price moved Down by -3.35% from its previous close of Rs 623.5.
Lincoln Pharmaceuticals Limited share price trend is Down with a total of 62529 stocks traded till now. It has touched an intraday high of Rs 777.7 and an intraday low of Rs 600. The LINCOLN trading at 602.60, Down by Rs. -20.90, or -3.35 percent which suggests that most of the Traders are anticipating that the price of LINCOLN share should go Down and the Stop Loss will be around 615.45.
The market cap of Lincoln Pharmaceuticals Limited is ₹706.4 (in Cr) as of Sep 14, 2026.
The current price to earning ratio for Lincoln Pharmaceuticals Limited as of Sep 14, 2026 is 12.52.
The current price to book ratio for Lincoln Pharmaceuticals Limited as of Sep 14, 2026 is 1.52.
The highest price of Lincoln Pharmaceuticals Limited stock is ₹770 in the last 52-week.
The lowest price of Lincoln Pharmaceuticals Limited stock is ₹440 in the last 52-week.
Lincoln Pharmaceuticals Limited share trading at ₹602.60, Down by Rs. -20.90, or -3.35 percent which suggests that most of the traders are anticipating that the price of LINCOLN share should go Down.
In 2026, Stock price target for Lincoln Pharmaceuticals Limited (LINCOLN) will be around ₹461.3 on downside and ₹642.4 on upside. Lincoln Pharmaceuticals Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Lincoln Pharmaceuticals Limited (LINCOLN) will be around ₹642.4 on downside and ₹824.4 on upside. Lincoln Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Lincoln Pharmaceuticals Limited (LINCOLN) will be around ₹824.4 on downside and ₹882.1 on upside. Lincoln Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Lincoln Pharmaceuticals Limited (LINCOLN) will be around ₹953 Lincoln Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of LINCOLN.
The price of Lincoln Pharmaceuticals Limited (LINCOLN) shares moved by -3.35%. The short-term trend for LINCOLN share price is Down. It implies that the share price of LINCOLN will stay the same tomorrow and that intraday traders should treat VWAP at 615.45 as a stop loss. Investors with a long-term outlook can track LINCOLN long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of LINCOLN stock is 612.9. Compared to the current market price of 602.60 INR, the LINCOLN stock is Undervalued by 1.7%.
As per the fundamental analysis of Lincoln Pharmaceuticals Limited (LINCOLN), it is of Standard quality in terms of earnings and profit margins with an EPS of 51.12. Lincoln Pharmaceuticals Limited book value per share as of today is 396.34. The current price to book ratio for LINCOLN as of Sep 15, 2026 is 1.52.
NSE:LINCOLN News & Other Useful Information about LINCOLN Share Price
Peer Comparison of NSE: LINCOLN
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1835.00 | 16.35 | 97.89 |
| DIVISLAB | 9198.00 | 115.55 | 663.06 |
| MEDICAMEQ | 318.20 | 12.15 | 208.08 |
| CIPLA | 1351.00 | 51.67 | 434.03 |
| DRREDDY | 1145.00 | 53.19 | 380.63 |
| TORNTPHARM | 4850.00 | 87.32 | 235.7 |
| BIOCON | 382.00 | 1.27 | 166.51 |
| LUPIN | 2063.20 | 154.86 | 718.37 |
| ALKEM | 5161.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1660.00 | 46.49 | 403.84 |
| ABBOTINDIA | 26125.00 | 766.11 | 2448.41 |
| GLAXO | 2818.90 | 63.65 | 147.25 |
| IPCALAB | 1932.40 | 56.72 | 329.23 |
| LAURUSLABS | 1926.90 | 20.74 | 102.57 |
| LALPATHLAB | 1906.40 | 39.68 | 157.23 |
| PFIZER | 4041.60 | 170.54 | 963.41 |
| AJANTPHARM | 3510.40 | 89.3 | 363.23 |
| SANOFI | 3131.00 | 158.05 | 332.96 |
| NATCOPHARM | 819.15 | 82.14 | 481.67 |
| APLLTD | 824.75 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2371.70 | 1.24 | 881.78 |
| AAREYDRUGS | 98.50 | 2.39 | 53.38 |
| JUBLPHARMA | 1011.95 | 4.35 | 145.63 |
| SPARC | 188.00 | 48.14 | 40.45 |
| GRANULES | 872.60 | 23.25 | 180.42 |
| ASTRAZEN | 6695.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2570.60 | 55.52 | 285.6 |
| FDC | 349.70 | 21.19 | 161.21 |
| HIKAL | 212.22 | 9.34 | 96.63 |